Deuterium Capital Management’s Core Scientific CORZ Stock Holding History

Deuterium Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-300,000	Closed	-$4.49M	–	25
2026 Q1	$4.49M	Hold	300,000	–	–	5.22%	7
2025 Q4	$4.37M	Hold	300,000	–	–	6.34%	6
2025 Q3	$5.38M	Hold	300,000	–	–	7.79%	6
2025 Q2	$5.12M	Sell	300,000 -115,000	-28%	-$1.15M	9.61%	5
2025 Q1	$3M	Buy	415,000 +224,277	+118%	+$2.55M	6.69%	6
2024 Q4	$2.72M	Buy	190,723 +70,723	+59%	+$1.04M	7.12%	5
2024 Q3	$1.42M	Buy	120,000 +19,000	+19%	+$197K	2.61%	8
2024 Q2	$939K	Buy	+101,000	New	+$516K	1.58%	13

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Deuterium Capital Management's CORZ Position: Q2 2026 in Review

Deuterium Capital Management sold out of Core Scientific (CORZ) in Q2 2026, closing a stake of 300,000 shares — an estimated $4.49M sold.

Deuterium Capital Management first reported a position in CORZ in Q2 2024 and held it in 8 quarters. The position peaked at $5.38M in Q3 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Deuterium Capital Management reported no remaining Core Scientific position as of Q2 2026 after selling out during the quarter.
Deuterium Capital Management sold 300,000 Core Scientific shares in Q2 2026, an estimated $4.49M.
Deuterium Capital Management first reported a position in Core Scientific in Q2 2024 and held it in 8 quarters.
Deuterium Capital Management's Core Scientific position peaked at $5.38M in Q3 2025.
412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Deuterium Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.